Noonan Syndrome in South Africa: Clinical and Molecular Profiles

被引:13
|
作者
Tekendo-Ngongang, Cedrik [1 ,2 ,7 ]
Agenbag, Gloudi [1 ,2 ]
Bope, Christian Domilongo [1 ,2 ,3 ,4 ]
Esterhuizen, Alina Izabela [1 ,2 ,5 ]
Wonkam, Ambroise [1 ,2 ,6 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Human Genet, Cape Town, South Africa
[2] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Human Genet, Cape Town, South Africa
[3] Univ Kinshasa, Fac Sci, Dept Math, Kinshasa, DEM REP CONGO
[4] Univ Kinshasa, Fac Sci, Dept Comp Sci, Kinshasa, DEM REP CONGO
[5] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa
[6] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa
[7] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA
基金
英国惠康基金; 英国医学研究理事会;
关键词
Noonan syndrome; multigene panel testing; targeted next-generation sequencing; RASopathies; Ras/MAPK signaling pathway; South Africa; PARTICLE MESH EWALD; TYROSINE-PHOSPHATASE; GERMLINE MUTATIONS; RARE VARIANTS; DIAGNOSIS; FEATURES; PATHWAY; GENES; SOS2;
D O I
10.3389/fgene.2019.00333
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Noonan Syndrome (NS) is a common autosomal dominant multisystem disorder, caused by mutations in more than 10 genes in the Ras/MAPK signaling pathway. Differential mutation frequencies are observed across populations. Clinical expressions of NS are highly variable and include short stature, distinctive craniofacial dysmorphism, cardiovascular abnormalities, and developmental delay. Little is known about phenotypic specificities and molecular characteristics of NS in Africa. The present study has investigated patients with NS in Cape Town (South Africa). Clinical features were carefully documented in a total of 26 patients. Targeted Next-Generation Sequencing (NGS) was performed on 16 unrelated probands, using a multigene panel comprising 14 genes: PTPN11, SOS1, R1T1, A2ML1, BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1, SHOC2, and SPRED1. The median age at diagnosis was 4.5 years (range: 1 month-51 years). Individuals of mixed-race ancestry were most represented (53.8%), followed by black Africans (30.8%). Our cohort revealed a lower frequency of pulmonary valve stenosis (34.6%) and a less severe developmental milestones phenotype. Molecular analysis found variants predicted to be pathogenic in 5 / 16 cases (31.2%). Among these mutations, two were previously reported: MAP2K1-c.389A>G (p.Tyr130Cys) and PTPN11-c.1510A>G (p.Met504Val); three are novel: CBL-c.2520T>G (p.Cys840Trp), PTPN11- c.1496C T (p.Ser499Phe), and MAP2K1 - c.200A>C (p.Asp67A1a). Molecular dynamic simulations indicated that novel variants identified impact the stability and flexibility of their corresponding proteins. Genotype-phenotype correlations showed that clinical features of NS were more typical in patients with variants in MAP2K1. This first application of targeted NGS for the molecular diagnosis of NS in South Africans suggests that, while there is no major phenotypic difference compared to other populations, the distribution of genetic variants in NS in South Africans may be different.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Clinical and Genetic Characteristics of Noonan Syndrome and Noonan-like Diseases
    Orlova, A. A.
    Dadali, E. L.
    Polyakov, A. V.
    [J]. RUSSIAN JOURNAL OF GENETICS, 2020, 56 (05) : 540 - 547
  • [22] Clinical and Genetic Characteristics of Noonan Syndrome and Noonan-like Diseases
    A. A. Orlova
    E. L. Dadali
    A. V. Polyakov
    [J]. Russian Journal of Genetics, 2020, 56 : 540 - 547
  • [23] Molecular IgE sensitization profiles of urban and rural children in South Africa
    Mittermann, Irene
    Dzoro, Sheron
    Gattinger, Pia
    Botha, Maresa
    Basera, Wisdom
    Facey-Thomas, Heidi E.
    Gaunt, Ben
    Genuneit, Jon
    Gray, Claudia L.
    Hlela, Carol
    Flicker, Sabine
    Lunjani, Nonhlanhla
    Mankahla, Avumile
    Ramjith, Jordache
    Valenta, Rudolf
    Levin, Michael E.
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, 32 (02) : 234 - 241
  • [24] LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis
    Kirsten M. Farncombe
    Emily Thain
    Carolina Barnett-Tapia
    Hamid Sadeghian
    Raymond H. Kim
    [J]. BMC Medical Genomics, 15
  • [25] LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis
    Farncombe, Kirsten M.
    Thain, Emily
    Barnett-Tapia, Carolina
    Sadeghian, Hamid
    Kim, Raymond H.
    [J]. BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [26] HEMATOLOGICAL MANIFESTATIONS OF NOONAN SYNDROME: A CLINICAL CASE
    Lopes, R.
    Morais, S.
    Alvares, S.
    Costa, E.
    Barbot, J.
    [J]. HAEMATOLOGICA, 2012, 97 : 514 - 514
  • [27] Marfan syndrome in South Africa - a molecular genetic approach to diagnosis
    Child, A.
    Comeglio, P.
    Arno, G.
    Beighton, P.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (09): : 845 - 847
  • [28] Noonan Syndrome: Introduction and Basic Clinical Features
    Rohrer, T.
    [J]. HORMONE RESEARCH, 2009, 72 : 3 - 7
  • [29] Clinical Manifestations of Noonan Syndrome and Related Disorders
    Breilyn, Margo Sheck
    Mehta, Lakshmi
    [J]. PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2019, 16 : 428 - 434
  • [30] Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa
    Van Hougenhouck-Tulleken, W
    Chan, I
    Hamada, T
    Thornton, H
    Jenkins, T
    McLean, WHI
    McGrath, JA
    Ramsay, M
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (02) : 413 - 423